<DOC>
	<DOCNO>NCT00069602</DOCNO>
	<brief_summary>Continuous glucose monitor may useful treatment child Type 1 diabetes mellitus . The purpose study determine whether two FDA-approved continuous glucose monitor , Continuous Glucose Monitoring System ( CGMS ) GlucoWatch G2TM Biographer ( GW2B ) , sufficiently accurate use future study characterize glucose level child .</brief_summary>
	<brief_title>Assessing Continuous Glucose Monitors Healthy Children</brief_title>
	<detailed_description>The characterization glucose level healthy child day nighttime critical interpretation glucose level diseases diabetes . This study conduct DirecNet Study Group determine whether two FDA-approved continuous glucose monitor sufficiently accurate . The study conduct five clinical center enrol approximately 20 healthy child ( age 7 17 year old ) Type 1 Type 2 diabetes history disease immediate family . Each participant hospitalize approximately 26 hour assess accuracy continuous glucose monitor compare serum glucose determination .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<criteria>Inclusion Criteria Weight &gt; = 16.0 kg ( 35 lb ) Body mass index 10th 90th percentile age sex HbA1c within normal limit Hematocrit within normal limit Exclusion Criteria History diabetes History positive islet cell antibody test Family history Type 1 Type 2 diabetes sibling parent Medication use type 7 day prior study entry Skin abnormalities contraindicate device use</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Continuous Glucose Monitoring Devices</keyword>
	<keyword>Blood glucose profile normal child</keyword>
	<keyword>Blood glucose profile non-diabetic child</keyword>
</DOC>